Clinical Trial Update: Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating platinum doublets with hypofractionated radiotherapy for non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: WITHDRAWN